Showing 1 - 13 results of 13 for search 'Jürgen Floege', query time: 0.02s
Refine Results
-
1
Dilemma of missing specific disease codes: an approach to assess the incidence and prevalence of a rare nephrology disease by Matthias Roll, Amadeus Gladbach, Isabella Selinger, Thomas Hardt, Helena Himmelhaus, Christian Jacob, Timotheus Stremel, Julia Theil, Jürgen Floege
Published 2025-07-01Get full text
Article -
2
WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ASSOCIATED WITH LONG-TERM RENAL OUTCOMES IN IGA NEPHROPATHY: 36-WEEK RESULTS FROM THE PHASE 2B ORIGIN STUDY by Jonathan Barratt, Bart Maes, Celia Lin, Xuelian Wei, Sean Barbour, Richard Phoon, Sung Gyun Kim, Vladimir Tesar, Jürgen Floege, Vivekanand Jha, Richard Lafayette
Published 2024-04-01Get full text
Article -
3
-
4
WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
Published 2024-04-01Get full text
Article -
5
WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL by Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Jonathan Barratt
Published 2024-04-01Get full text
Article -
6
WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
Published 2024-04-01Get full text
Article -
7
WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
Published 2024-04-01Get full text
Article -
8
WCN24-1414 ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY by Jonathan Barratt, Bart Maes, Rubeen Israni, Xuelian Wei, Jürgen Floege, Vivekanand Jha, Vladimir Tesar, Hong Zhang, Sean Barbour, Hitoshi Suzuki, Hernan Trimarchi, Celia Lin, Richard Lafayette
Published 2024-04-01Get full text
Article -
9
WCN25-2470 Long-term Results from the ORIGIN Phase 2b Study of Atacicept for the Treatment of IgAN by Vivekanand Jha, Richard Lafayette, Sean Barbour, Robert Brenner, Kerry Cooper, Xuelian Wei, Necmi Eren, Jürgen Floege, Sung Gyun Kim, Bart Maes, Richard Phoon, Harmeet Singh, Vladimír Tesař, Jonathan Barratt
Published 2025-02-01Get full text
Article -
10
Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning by John W. Larkin, Suman Lama, Sheetal Chaudhuri, Joanna Willetts, Anke C. Winter, Yue Jiao, Manuela Stauss-Grabo, Len A. Usvyat, Jeffrey L. Hymes, Franklin W. Maddux, David C. Wheeler, Peter Stenvinkel, Jürgen Floege, on behalf of the INSPIRE Core Group
Published 2024-10-01Get full text
Article -
11
Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis by Eva M Buhl, Sonja Djudjaj, Barbara M Klinkhammer, Katja Ermert, Victor G Puelles, Maja T Lindenmeyer, Clemens D Cohen, Chaoyong He, Erawan Borkham‐Kamphorst, Ralf Weiskirchen, Bernd Denecke, Panuwat Trairatphisan, Julio Saez‐Rodriguez, Tobias B Huber, Lorin E Olson, Jürgen Floege, Peter Boor
Published 2020-01-01Get full text
Article -
12
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway. by Krzysztof Kiryluk, Yifu Li, Zina Moldoveanu, Hitoshi Suzuki, Colin Reily, Ping Hou, Jingyuan Xie, Nikol Mladkova, Sindhuri Prakash, Clara Fischman, Samantha Shapiro, Robert A LeDesma, Drew Bradbury, Iuliana Ionita-Laza, Frank Eitner, Thomas Rauen, Nicolas Maillard, Francois Berthoux, Jürgen Floege, Nan Chen, Hong Zhang, Francesco Scolari, Robert J Wyatt, Bruce A Julian, Ali G Gharavi, Jan Novak
Published 2017-02-01Get full text
Article -
13
Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR by Dana Kim, Brendon L. Neuen, Jicheng Lv, Michelle A. Hladunewich, Vivekanand Jha, Lai Seong Hooi, Helen Monaghan, Robert A. Fletcher, Laurent Billot, Vlado Perkovic, Hong Zhang, Muh Geot Wong, Adeera Levin, Daniel Cattran, David W. Johnson, David Wheeler, Heather N. Reich, Helen Monaghan, Hong Zhang, Jicheng Lv, Jürgen Floege, Lai Seong Hooi, Mark Woodward, Meg Jardine, Michelle A. Hladunewich, Ming-hui Zhao, Muh Geot Wong, Rajiv Agarwal, Richard Glassock, Sean Barbour, Tak Mao Chan, Vivekanand Jha, Vlado Perkovic, Yangfeng Wu, Zhihong Liu
Published 2025-06-01Get full text
Article